GlassScriptPhysician profile
Noha Elnagar
NPI 1215324132
$9,394.29
in general payments reported to CMS, 2019-2025
31 companies · $4,507 in 2025
The $4,507 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $559 · 2022: $15.37 · 2023: $661 · 2024: $3,651 · 2025: $4,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,670 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,375 · Travel and Lodging: $1,713 · Long Term Medical Supply Or Device Loan: $49.95 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,670.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,375.00 |
| Travel and Lodging | $1,713.34 |
| Long Term Medical Supply Or Device Loan | $49.95 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $3,525.57 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $2,351.92 | 2021-2025 | Minimed 780g |
| Novo Nordisk INC | $605.30 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Corcept Therapeutics | $426.83 | 2023-2025 | Korlym |
| Dexcom, INC. | $395.43 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $367.98 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $287.04 | 2023-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Astrazeneca Pharmaceuticals LP | $233.36 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.10 | 2023 | |
| Insulet Corporation | $130.64 | 2021-2024 | Omnipod |
| Inari Medical, INC. | $116.78 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vertex Pharmaceuticals Incorporated | $108.27 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.72 | 2021-2025 | Jardiance |
| Si-Bone, INC. | $88.79 | 2024 | |
| Integra Lifesciences Corporation | $87.52 | 2024 | Biodoptix, Biofix, Biodrestore |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $66.13 | 2023 | |
| Lifenet Health | $55.55 | 2025 | Allograft Vmis Delivery System, Pliafx Flo |
| Depuy Synthes Sales INC. | $54.03 | 2025 | |
| Radius Health, INC. | $37.55 | 2024-2025 | Tymlos |
| Gilead Sciences, INC. | $27.64 | 2021 | |
| Beta Bionics, INC. | $24.03 | 2024 | Ilet Bionic Pancreas |
| Ascendis Pharma Endocrinology INC | $20.86 | 2025 | Yorvipath |
| Sanofi-Aventis U.S. LLC | $20.45 | 2024 | |
| Mannkind Corporation | $18.11 | 2025 | |
| Sequel Med Tech, LLC | $17.77 | 2025 | Twiist |
| Amgen INC. | $16.63 | 2025 | Tepezza |
| Janssen Pharmaceuticals, INC | $16.33 | 2021 | |
| Cequr Corporation | $16.20 | 2024 | Cequr Simplicity |
| Amarin Pharma, INC. | $15.36 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.99 | 2025 | Unithroid |
| Merck Sharp & Dohme LLC | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noha Elnagar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.